Entheon Biomedical Corp. (ENTBF)
Develops psychedelic-based medicines to treat addiction and substance abuse disorders.
$0.00-0.08%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-95.1%
The outlook
ENTBF trades at $0.0037, sitting well below both its 50- and 200-day moving averages and near the bottom of its 52-week range. Analyst coverage appears thin. The stock's overall positioning reflects significant weakness in recent price action.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Market cap
$51,278
52-wk high
$0.10
52-wk low
$0.00
50-day avg
$0.03
200-day avg
$0.06
Trailing P/E
0.4